Bausch, Teva face lawsuit for delay in generic version of...

2025-09-23 14:17:43 ET More on Teva Pharmaceutical, Bausch Health Companies Olanzapine LAI (TEV-'749) Phase 3 SOLARIS Data Presentation Bausch Health: Repricing Continues As Deleveraging Gains Traction Teva Pharmaceutical Industries Limited (TEVA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript Insider trades: Salesforce, Broadcom among notable names this week Teva gets FDA fast track status for multiple system atrophy drug Read the full article on Seeking Alpha For further details see: Bausch, Teva face lawsuit for delay in generic version of Xifaxan